T. Rowe Price Investment Management, Inc. 10x Genomics, Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $163 Billion
- Q1 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 2,204,430 shares of TXG stock, worth $49.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,204,430
Previous 1,141,044
93.19%
Holding current value
$49.4 Million
Previous $63.9 Million
29.57%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding TXG
# of Institutions
308Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$204 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$166 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$141 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$135 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$116 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $2.13B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...